Over the past several decades, marijuana has remained a prevalent and complex issue within the U.S. government.
Complicated and sometimes outdated laws pertaining to medical and recreational marijuana often make the matter harder to navigate.
If the Biden administration moves forward with a recently proposed plan aiming to reclassify marijuana, the results could make major waves within the U.S. marijuana industry. It could also mean a great deal for Mississippi.
Proposal to reclassify marijuana
The proposed plan would reclassify marijuana from a Schedule I drug to a Schedule III.
A Schedule I drug is characterized by a drug that has no medical use. Any drug classified as Schedule I is illegal. Examples of Schedule I drugs include heroin, LSD and ecstasy.
A Schedule III drug, on the other hand, is characterized by a low chance of physical or psychological dependence. Examples of Schedule III drugs include Tylenol or anabolic steroids.
The scale goes from Schedule I to Schedule IV.
Marijuana became a Schedule I drug under the Controlled Substance Act of 1970.
The Agriculture Improvement Act, also known as the Farm Bill, of 2018 shifted marijuana’s status slightly. The drug is still classified as Schedule I, but the bill made products containing less than 0.3% of THC, the most intoxicating component in cannabis, legal.
If the Biden administration implements the proposed plan, the state of marijuana will change drastically throughout the nation, but maybe not in the way you think.
The plan will not actually legalize marijuana. All it would do is change the drug’s classification.
The plan is a baby step toward the national legalization of marijuana. However, the most significant change this plan would bring is within the research field.
Since marijuana is currently classified as a Schedule I drug, the requirements to be able to research the drug are extremely strict and the steps are difficult to take.
A reclassification would mean more labs and pharmacy companies can begin more extensive research into medical marijuana and its uses.
The proposed plan still awaits public comment and will not reach a finalized decision in the near future.
More details on proposed plan: Biden administration plans to drastically change federal rules on marijuana
Coming fall 2024: Ole Miss to offer medical marijuana master’s degree. Here’s what to know
What would it mean for Mississippi?
For Mississippi, the main changes that would come with the plan center around research.
Robert Welch, director of the National Center for Cannabis Research and Education at the University of Mississippi, said reclassifying marijuana would open up research significantly due to the current restraints placed on researching Schedule I drugs.
“If you want to work with cannabis, you have to get a DEA (Drug Enforcement Administration) Schedule I license,” Welch said. “Well, that’s a pretty arduous and costly level to get just because you’re handling illicit material.”
If the plan is put into place, the cannabinoid industry has the potential to boom in the coming years.
“I think a lot more pharmaceutical companies are going to jump into the fray on development of different cannabinoid products,” Welch said. “Companies will be a little more tempted to involve themselves with these products because (research regulations would be) less strict.”
Since 1968, the University of Mississippi has been the only federally funded facility growing marijuana for research purposes. Eventually, if other facilities around the state and the nation are able to grow marijuana for research, some of the burden will lift from the University of Mississippi’s facility.
“We’re the ones that have been supplying all that material,” Welch said. “Well, this could potentially open that up a great deal. That’s going to take time to get there.”
Because of loopholes within the 2018 Farm Bill and widely unenforced laws, many gas stations and vape stores, including those in Mississippi, today sell products that contain intoxicating cannabinoids. An example of these products is a vape containing Delta 8, a popular cannabis compound.
“What happened is folks started interpreting (the 2018 Farm Bill) such that they foresee it as legal to be able to sell all this intoxicating stuff,” Welch said. “But that’s not what the bill meant. It was trying to help folks that were interested in creating hemp products and CBD products. But, there’s wording in that bill that talks about derivatives.”
These unregulated derivatives, Welch said, often contain additives including hydrochloric acid. Welch said he and his students have tested products like Delta 8 in the lab and have found several impurities and byproducts.
The reclassification of marijuana would put constraints on these products.
More in state news: See which Mississippi high school earned the highest ranking from U.S. News list
What comes next?
All of these potential effects of the proposed plan depend on the plan’s wording, Welch said.
The proposed plan will next receive public comment, which will include feedback from experts like Welch.
Welch anticipates some initial confusion over what the plan actually means for the U.S.
The proposed plan will not have clear, immediate effects. Eventually, however, the plan could create drastic changes when it comes to how marijuana is regulated and perceived within the U.S.
“This is just the next step toward a more robust federally approved program and then a recreational arm,” Welch said. “This has to happen first.”
Got a news tip? Contact Mary Boyte at mboyte@jackson.gannett.com
This article originally appeared on Mississippi Clarion Ledger: The future of marijuana in MS under proposed Biden national plan
Nebraska voters will decide this Election Day on a pair of citizen-initiated ballot measures regulating medical cannabis access to authorized patients.
State regulators last week affirmed that advocates Nebraskans for Medical Marijuana had gathered the requisite number of signatures to place the measures before voters.
The two measures are complementary. The first permits qualified patients to possess and use cannabis. The second measure regulates the production and distribution of cannabis to those authorized patients. Advocates had to frame the issue as two separate ballot questions in order to not run afoul of the state’s ‘single subject’ rule. In 2020, the state Supreme Court invalidated a similar stand-alone measure for addressing issues that it deemed were “not naturally and necessarily connected to the [initiative’s] primary purpose.” A 2022 effort failed to obtain sufficient signatures to qualify for the ballot.
“States have a proven track record of safely and effectively regulating medical marijuana,” NORML’s Deputy Director Paul Armentano said. “After November, Nebraskans will no longer be forced to choose between their medicine or their freedom.”
Thirty-eight states, the District of Columbia, and several US territories regulate medical cannabis products. Statewide polling indicates that between 70 percent and 80 percent of Nebraskans support legalizing medical marijuana access.
Nebraska is one of at least four states where cannabis-related initiatives will appear on November’s ballot. Voters in Florida, North Dakota, and South Dakota, who also will be deciding on adult-use legalization measures this fall.
In Texas, voters in the cities of Bastrop (population 11,200), Dallas (population: 1.3 million), and Lockhart (population 15,000) will decide on municipal ballot measures prohibiting local law enforcement from making low-level marijuana-related arrests.
I’m a Registered Dietitian and Holistic Cannabis Practitioner, and it is my mission to teach you how to harness the power of the cannabis plant to naturally manage the stress of every day life so you can bring back joy, build better relationships, and live a better quality of life.
Cannabis changed my life, and it can change yours, too.
Take 1-2 gummies at a time, depending on your tolerance level
Adjust your serving size as needed
Take 30 minutes before bed, depending on your needs
Wide-mouth jars with child-resistant lids
Keep out of reach of children
Individual results may vary
Ingredients
Organic cane sugar, distilled water, organic tapioca syrup, fruit pectin, organic vanilla, and chamomile flavor extract, citric acid, potassium citrate, fruit & vegetable extracts for color, and natural terpenes.
DESCRIPTION
These vanilla chamomile sleep gummies aren’t just any ordinary gummies.
They’re specially crafted with your peaceful slumber in mind, designed to help you fall asleep faster and stay asleep longer.
Each Sleepy Bliss Gummy is infused with a powerful blend of 5mg ∆9-THC, 5mg CBN, and 5mg CBD. This trio works harmoniously to lull you into a state of deep relaxation, preparing your body and mind for a night of restorative sleep.
We’ve made sure that dosing is as simple as possible. No more complicated measurements or guesswork. With our simplified dosing, you can easily take your daily serving and enjoy the benefits of these gummies without any hassle.
These Sleepy Bliss Gummies contain a blend of various Indica strains, making them perfect for winding down after a long day or enjoying a restful weekend.
Whether you’re winding down after a long day or looking for a relaxing way to spend your weekend, Sleepy Bliss Gummies are your go-to choice.
And the best part? NO groggy, foggy, or hungover feeling in the morning!
A Safe & Legal Option
Many ask, “How can these gummies contain 5mg of THC and be less than 0.3% THC?” 🤔
The answer is found in math. Each gummy weighs 5 grams or 5,000 milligrams. And 0.3% of 5,000 = 15 milligrams. That means this product is under the legal limit.
Therefore, these gummies contain less than 0.3% Δ9-THC by weight of each teaspoon, making them Federally legal under the 2018 Farm Bill.
And yes, these gummies are exclusively made with delta-9 THC; we do not sell or support delta-8 THC products at this time.
We absolutely understand your hesitation in ordering cannabis online.
Even with the increasing acceptance of cannabis, plenty of challenges still come with it, making it understandable if you feel uncertain. We assure you this purchase is legal and worth every penny.
Lab Testing
Independent, third-party lab testing ensures that only the highest quality product is delivered to you. Our lab test results are produced by SC Labs, formerly Botanacor Laboratories. Each product is thoroughly tested to ensure purity, potency, and effect. Free from microbial contaminants, heavy metals, and residual solvents – quality is our standard! You can cross-check our promise by reviewing the lab test in the image gallery of each product.
The Highest Quality
All Emily Kyle products are processed in Denver, Colorado, by VivaOil, LLC. Our products are proudly made in the USA in a third-party tested, cGMP, FDA-registered & certified facility.
Our products are formulated with more than just THC and CBD. We include minor cannabinoids and a blend of terpenes known to enhance wellness. Through gentle CO2 extraction, we capture the whole plant with a range of cannabinoids and terpenes. These compounds work together synergistically to enhance results. Beyond taste and flavor, they provide a wealth of potential health benefits. Terpenes and minor cannabinoids are essential ingredients to a true full-spectrum experience.
Shipping Options
We ship packages with the United States Postal Services (USPS). All shipments are legal based on their hemp-based product requirements. Your package will arrive in an unmarked box or envelope for discrete arrival. Unfortunately, current laws prevent us from shipping to any country outside of the US at this time.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult a physician before use if you have a serious medical condition or use prescription medications. A Doctor’s advice should be sought before using this and any supplemental product. By using this site, you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void where Prohibited by Law. Our products contain less than 0.3% THC.